Key Takeaways
- • Q3 2026 Revenue Guidance: Analysts expect Beyond Air to report Q3 2026 revenue of $2.19 million with earnings of -$0.83 per share, reflecting continued losses despite revenue growth trajectory.
- • Strong YoY Revenue Growth: Beyond Air generated $1.8 million in Q2 2026 revenue, representing 127.82% year-over-year growth, demonstrating accelerating commercial traction in its medical device business.
- • Significant Hedge Fund Repositioning: Institutional investors showed divergent conviction, with 25 funds reducing positions versus 13 adding shares in recent quarters; major exits included Balyasny Asset Management (-86.1%, ~$6.6M), Kingdon Capital (-95.0%, ~$2.1M), and Susquehanna International (-100.0%, ~$102K).
- • Selective Institutional Support: Alyeska Investment Group initiated a position with 759,061 shares (~$1.75M), and Bleichroeder LP expanded holdings by 134.3%, signaling selective institutional confidence despite broader fund reductions.
- • Stock Performance Pressure: YTD performance declined 52.41% as of mid-2026, with the stock trading near $0.55 in April 2026, reflecting investor skepticism about the company's path to profitability despite revenue acceleration.
Summary
Beyond Air Inc. ($XAIR) is preparing to release Q3 2026 earnings with consensus analyst expectations for $2.19 million in revenue and a net loss of $0.83 per share. The medical device and biopharmaceutical company, which develops the Lungfit platform, continues to demonstrate revenue momentum even as profitability remains elusive. Q2 2026 revenue reached $1.8 million, marking a 127.82% increase from the same period in 2025, indicating accelerating commercial adoption of its technology.
Hedge fund and institutional investor activity reveals mixed sentiment. Over the most recent quarters tracked, 13 institutional investors added Beyond Air positions while 25 reduced their holdings. The largest exits were particularly notable: Balyasny Asset Management divested 2.87 million shares (86.1% of position) for approximately $6.63 million in Q3 2025, while Kingdon Capital Management eliminated 95% of its stake (889,850 shares, ~$2.1M). Susquehanna International Group completely exited its position, selling 44,306 shares valued at approximately $102,000. Vanguard Group also reduced exposure by 42.1% in Q4 2025.
Offsetting these institutional exits, select investors signaled conviction in Beyond Air's longer-term potential. Alyeska Investment Group initiated a new position with 759,061 shares valued at approximately $1.75 million in Q3 2025, while Bleichroeder LP expanded its holdings by 134.3% (49,573 shares, ~$115K). Geode Capital Management added 24,695 shares in Q4 2025. This bifurcated institutional response—simultaneous large exits and targeted entries—suggests divergent views on the company's commercial execution and timeline to profitability.
Beyond Air's stock performance has lagged significantly, declining 52.41% year-to-date through mid-2026, with shares trading near $0.55 in April 2026. The company's inability to generate profitability despite robust revenue growth appears to be pressuring valuation, though analyst consensus maintains a bullish stance on the underlying commercial opportunity. The company's Q3 2026 earnings release will be critical for assessing whether revenue growth rates can accelerate toward levels that justify current institutional attention and eventual path to positive earnings.
Hedge fund and institutional investor activity reveals mixed sentiment. Over the most recent quarters tracked, 13 institutional investors added Beyond Air positions while 25 reduced their holdings. The largest exits were particularly notable: Balyasny Asset Management divested 2.87 million shares (86.1% of position) for approximately $6.63 million in Q3 2025, while Kingdon Capital Management eliminated 95% of its stake (889,850 shares, ~$2.1M). Susquehanna International Group completely exited its position, selling 44,306 shares valued at approximately $102,000. Vanguard Group also reduced exposure by 42.1% in Q4 2025.
Offsetting these institutional exits, select investors signaled conviction in Beyond Air's longer-term potential. Alyeska Investment Group initiated a new position with 759,061 shares valued at approximately $1.75 million in Q3 2025, while Bleichroeder LP expanded its holdings by 134.3% (49,573 shares, ~$115K). Geode Capital Management added 24,695 shares in Q4 2025. This bifurcated institutional response—simultaneous large exits and targeted entries—suggests divergent views on the company's commercial execution and timeline to profitability.
Beyond Air's stock performance has lagged significantly, declining 52.41% year-to-date through mid-2026, with shares trading near $0.55 in April 2026. The company's inability to generate profitability despite robust revenue growth appears to be pressuring valuation, though analyst consensus maintains a bullish stance on the underlying commercial opportunity. The company's Q3 2026 earnings release will be critical for assessing whether revenue growth rates can accelerate toward levels that justify current institutional attention and eventual path to positive earnings.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.